Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

An analysis on the state of pharmaceutical drug pricing revealed that, despite rebates, consumers' out-of-pocket costs have grown faster than their insurers' prices. Today, an analysis published in ...

Donald Trump is the first American president to take an active interest in what is happening to patients when they buy drugs at a local pharmacy.

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...

Justine Mallatt ([email protected]), Bureau of Economic Analysis, Washington, D.C. Abe Dunn, Bureau of Economic Analysis. Lasanthi Fernando, Bureau of Economic Analysis. A 2023 KFF survey reported ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...